KVKonstantin N. Vagin

Konstantin N. Vagin

*This is an algorithmically generated author record based on publicly available information.

Konstantin N. Vagin has a total of 59 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Biomineral Complex with Probiotic and Detoxifying Properties for Recovery After Radiotherapy

    by Olga Ilinskaya, Konstantin Vagin, William Kurdy, Galina Yakovleva, Nazira Karamova, Pavel Zelenikhin, Alexey Kolpakov, Yuri Zuev

    Radiotherapy is a highly effective, safe cancer treatment, and about half of all cancer treatments involve lifesaving radiotherapy. Despite huge advances in technology that have made it safer and more effective, it is still not without side effects. They differ from patient to patient and can include fatigue, nausea, skin reactions, and hair loss, but dysbiosis is the most common complication associated with radiotherapy. Probiotics aimed at restoring the microbiome have found widespread use, but the problem of their rapid inactivation in the gastrointestinal tract has not yet been solved. Our study aims to confirm the effectiveness of a novel biomineral complex, based on a powdered clinoptilolite containing a rock loaded with lactobacilli for restoring the intestinal microbiome of mice exposed to radiation. Based on the 16S rRNA gene analysis, alpha-diversity and dynamics of changes in the fecal metagenome, as well as the functional potential of mice exposed to radiation, were studied, and the prospects of administering the biomineral complex to achieve positive effects were assessed. NMR analysis of the mineral carrier was carried out, and its safety was confirmed. Moreover, per os administration of the complex following irradiation led to a reduction in the level of chromosomal aberrations induced by irradiation. Thus, the biomineral complex has a microbiome-restoring effect and reduces radiation-induced clastogenesis.

  • Evaluation of the Therapeutic Effectiveness of a Composite Agent in the Treatment of Radiation–Thermal Damage

    by T. R. Gaynutdinov, K. N. Vagin, R. N. Nizamov

    The results of evaluating the therapeutic effectiveness of a composition based on antiradiation serum and metabolic products of bifidobacteria on laboratory animals subjected to experimental combined radiation and thermal effects are presented. In this work 124 mongrel white rats of both sexes with a live weight of 180–220 g were used as a biological model. The simulation of radiation damage to the body was carried out by a single external irradiation of animals on a Puma gamma installation with a 137Cs radiation source with an exposure dose of 8.5 × 10–2 A/kg in an absorbed dose of 7.5 Gy. Thermal injury was inflicted by applying a brass plate heated to 200°C with an area of 4.9 cm2 with a retention exposure of eight seconds to the trimmed area of the upper third of the thigh, inducing a grade III burn. The effectiveness of the therapeutic drug was evaluated according to the following criteria: changes in the titer of the compliment, the concentration of radiotoxin and thermotoxin, changes in the methodological parameters of the peripheral blood, the degree of burn damage, survival, and life expectancy of fallen animals. The results of tests evaluating the therapeutic effectiveness of the tested composition showed that a single subcutaneous injection of a medicinal product at a dose of 20 mg/kg followed by application of an anti-burn ointment based on bee podmore and St. John’s wort oil at intervals of 24, 48, and 168 h accelerated the formation of a burn scab by 1.75 times (p < 0.01), complete rejection of the burn scab increased by 1.15 times (p < 0.05), and the complete healing of the burn wound accelerated by 1.18 times compared with the control groups, thereby increasing the survival rate to 87.5% (p < 0.05) of animals exposed to two-factor exposure to the affected factors, while increasing the average life expectancy to 28.0 days versus 6.5 days in the control (irradiation + burn).

  • Development of a Therapeutic Agent Based on Escherichia coli, Assessment of Harmlessness and Antiradiation Activity

    by T. R. Gaynutdinov, K. N. Vagin

    The development and assessment of the safety and antiradiation activity of a therapeutic agent based on a culture of Escherichia coli strains PL-6 and KV-1 are presented. To obtain the antiradiation agent, the causative agent of colibacillosis was grown in meat-peptone broth in a thermostat at a temperature of 37°C for three days. The grown suspension was centrifuged at 3000 rpm for 50 min, and the supernatant was decanted. The sediment was brought to one billion cm3 with distilled water. Smears were prepared from the cultures grown and stained according to Gram to determine the purity and species of the culture grown. The prepared suspension was poured into sterile vials of 10, 50, or 100 cm3, sealed with rubber stoppers, and rolled with aluminum caps. They were labeled with an indication of the strain, radiation dose, and date. Irradiation of the microbial material was carried out on the Issledovatel γ-installation, with a 60Co source, an absorbed dose rate of 1.028 Gy/s, in the ranges of absorbed doses from 7.5 to 30.0 kGy with interdose intervals of 2.5 and 5.0 kGy. The degree of inactivation of γ-irradiated E. coli cultures was determined by seeding them on meat-peptone agar and thermostatting for 168 h, recording the presence or absence of microorganism growth. Studies have established that the timing and degree of growth of irradiated E. coli cultures of the PL-6 and KV-1 strains are directly dependent on the radiation dose; their complete inactivation occurs with irradiation at a dose of 25.0 kGy. Further studies have shown that the developed biopreparation obtained on the basis of E. coli is sterile, areactogenic, nontoxic, and harmless. The mechanism of formation of radioresistance of the organism against the background of application of antiradiation agents based on the E. coli strains PL-6 and KV-1 consisted in restoration of the hematological, biochemical, and immune parameters, which contributed to preservation of 66.7 to 83.3% of lethally irradiated animals.

  • Evaluation of the therapeutic effectiveness of a composite agent in the treatment of radiation-thermal damage

    by Timur R. Gaynutdinov, Konstantin N. Vagin, Ramzi N. Nizamov

    The paper presents the results of evaluating the therapeutic effectiveness of a composition based on anti-radiation serum and metabolic products of bifidobacteria on laboratory animals subjected to experimental combined radiation and thermal effects. 124 mongrel white rats of both sexes with a live weight of 180–220 g were used as a biological model in the work. The simulation of radiation damage to the body was carried out by a single external irradiation of animals on a Puma gamma installation with a 137Cs radiation source with an exposure dose of 8.5×10–2 A/kg in an absorbed dose of 7.5 Gy. Thermal injury was inflicted by applying a brass plate heated to 200°C with an area of 4.9 cm2 with a retention exposure of 8 seconds to the trimmed area of the upper third of the thigh, inducing a grade III burn. The effectiveness of the therapeutic drug was evaluated according to the following criteria: changes in the titer of the compliment, the concentration of radiotoxin and thermotoxin, changes in the methodological parameters of peripheral blood, the degree of burn damage, survival and life expectancy of fallen animals. The results of tests evaluating the therapeutic effectiveness of the tested composition showed that a single subcutaneous injection of a medicinal product at a dose of 20 mg/kg followed by application of an anti-burn ointment based on bee podmore and St. John’s wort oil at intervals of 24, 48 and 168 hours accelerated the formation of a burn scab by 1.75 times (p 0.01), complete rejection of the burn scab — by 1.15 times (p 0.05), the complete healing of the burn wound accelerated by 1.18 times compared with the control groups, thereby increasing the survival rate to 87.5% (p 0.05) of animals exposed to two-factor exposure to the affected factors, while increasing the average life expectancy to 28.0 days versus 6.5 days in the control (irradiation + burn).


  • Development of a Therapeutic Agent Based on Escherichia coli, Assessment of Harmlessness and Anti-Radiation Activity

    by Timur R. Gaynutdinov, Konstantin N. Vagin

    The paper presents the development, assessment of the safety and antiradiation activity of a therapeutic agent based on the culture of Escherichia coli strains “PL-6” and “KV-1”. To obtain the antiradiation agent, the causative agent of colibacillosis was grown in meat-peptone broth in a thermostat at a temperature of 37°C for 3 days. The grown suspension was centrifuged at 3000 rpm for 50 min, the supernatant was decanted. The sediment was brought to 1 billion cm3 with distilled water. Smears were prepared from the grown cultures and stained according to Gram to determine the purity and species of the grown culture. The prepared suspension was poured into sterile vials of 10, 50 or 100 cm3, sealed with rubber stoppers and rolled with aluminum caps, labeling with an indication of the strain, radiation dose and date. Irradiation of the microbial material was carried out on the γ-installation “Issledovatel”, source 60Co, absorbed dose rate of 1.028 Gy/sec, in the ranges of absorbed doses from 7.5 to 30.0 kGy with interdose intervals of 2.5 and 5.0 kGy. The degree of inactivation of γ-irradiated E. coli cultures was determined by seeding them on meat-peptone agar and thermostatting for 168 hours, recording the presence or absence of microorganism growth. The studies have established that the timing and degree of growth of irradiated E. coli cultures of the “PL-6” and “KV-1” strains are directly dependent on the radiation dose, their complete inactivation occurs with irradiation at a dose of 25.0 kGy. Further studies have shown that the developed biopreparation obtained on the basis of E. coli is sterile, areactogenic, non-toxic and harmless. The mechanism of formation of radioresistance of the organism against the background of application of antiradiation agents based on E. coli strains “PL-6” and “KV-1” consisted in restoration of hematological, biochemical and immune parameters, which contributed to preservation of 66.7 to 83.3٪ of lethally irradiated animals.


  • Open Access

    DETERMINATION OF THE CONTENT OF BIOORGANIC IODINE IN THE BODY OF ANIMALS RECEIVING IODINE COMPOUNDS AS COMPOSITION OF THE DIET

    by Radiation And Biological Safety Federal State Budgetary Scientific Institution Federal Center For Toxicological, V.G. Tyurin, В. Г. Семенов, Chuvash State Agrarian University, К. Н. Вагин, Y.M. Kurbangaleev, Т. Р. Гайнутдинов, Kazan Federal University, G.I. Rakhmatullina, K.V. Usoltsev, et al.

    The purpose of the research was to determine the content of bioorganic iodine in the body of rabbits and cows that received iodine compounds as part of the diet. Spectrophotometric studies established that 1 month after the start of the experiments, the amount of protein-bound iodine (BPI) in the blood serum of control rabbits fed OR was (44.33±1.45) μg/dm3; in those receiving a diet with iodine deficiency, there was a decrease to (26.43±1.95) μg/dm3 (by 39.8 %), in animals of the third group receiving OR + potassium iodide, the content of BSI in the blood serum was (48. 27±1.62) µg/dm3 (increase by 9.8 %); in animals of the fourth group that received OR + biologically active additive “Laminaria – sea kale BIO (BAA), (52.55 ± 2.13) μg/dm3 (increase by 21.4 %). The results of the enzyme immunoassay showed that changes in the amount of triiodothyronine (T3) and thyroxine (T4) in the blood serum of rabbits during the experiment were similar to changes in the amount of BSI in the blood serum determined by the spectrophotometric method. In cows, as milk yield increases from the dry period to the milking period, the amount of T3 in the blood serum of cows decreases by 19.2 %, and the amount of T4, on the contrary, gradually increases by 20.6 %. The amount of BSI in the blood serum of cows, as milk yield increases from the dry period to the milking period, decreases by 15.63 % and during the milking period is at the lower limit of the physiological norm for this type of animal (the norm for dairy cows is 50 μg/dm3). When correcting iodine deficiency by adding the drug Kayod, the amount of T3 in the blood serum of cows increased by 27.8 %; T4 – by 30.3 % (P<0.01), the number of BSI – by 24.91 % compared to the control group. The concentrations of protein-bound iodine in the blood of rabbits and thyroid hormones correlate with each other, and the two methods used complement each other.

  • Analysis of Genome Variability of Escherichia coli When Exposed to Ionizing Radiation

    by M. Yu. Gallyamova, K. N. Vagin, N. M. Vasilevsky, N. I. Hammadov

    The study of changes in the genetic apparatus of biological systems due to the influence of physical factors contributes to understanding the mechanisms of adaptation. The article is devoted to the analysis of the genome of the modified Escherichia coli PL-6 variant obtained as a result of repeated and gradually increasing exposure to 60Co γ rays at the Researcher facility. The integrity of the genetic material of the studied bacterial cells was checked by electrophoresis in 1.7% agarose gel. For the analysis of genome modifications, primers were designed to amplify several loci characterized by homology in a variety of E. coli strains. On the basis of the indicators of the number and size of amplified products using each of the presented primer combinations in E. coli before and after gamma irradiation, a significant change in the genome was established.

  • Open Access

    Activation of the Immune System against the Background of Its Imbalance Caused by Agents of Radiation Nature

    by Konstantin Vagin, Timur Gaynutdinov, Gulnaz Rakhmatullina, Rustam Nizamov, Marina Gallyamova, Konstantin Sychev, Vladimir Semenov

    By conjugating a radioantigen (o-quinone) with a protein - Esherichia coli endotoxin, a stable polyantigen complex-protein-quinoid radioantigen (BChA) - o-quinone imine (C6H10O-NH - protein) was obtained, including haptenic (o-quinone) and protein part of the antigenic complex (Esherichia coli endotoxin). Using the above components (hyperimmune antiradiotoxic serum, ethanol extract of the Vita-Force apiphitopreparation, metabolic products of Bifidobacterium bifidum, Bacillus subtilis and a highly dispersed fraction of bentonite), a polyfunctional composition «Polyapisogen» was compiled, including polyglobulins (500 cm3 per 1 L),500 cm3 of 4% ethanol extract of the Vita-Force apiphitopreparation, in which a highly dispersed fraction of bentonite (20 g), metabolism products (2 g powder) and Bacillus subtilis metabolism products (4 g) are dissolved. The polyfunctional preparation obtained by the above-described technology is used as an activator of the immune system against the background of its imbalance induced by agents of a radiogenic nature. It was found that a single subcutaneous injection of the drug at a dose of 25 mg / kg of live weight (dry matter basis) had a radioprotective effect increasing the survival rate of affected animals upto 75%. The studies carried out can serve as a basis for the creation of polyfunctional radioprotective, immunoprotective and bioprotective agents not only for isolated, but also for combined lesions of the body by agents of radiogenic and non-radiogenic nature using polyglobulins, convalescent serums, bee products, metabolic products of probiotic microorganisms and mineral sorbents.

  • Influence of the combined action of mycotoxins and ionizing radiation on allergic sensitization

    by Eduard Iljasovich Semenov, Nailya N. Mishina, Almaz R. Valiev, Lilia E. Matrosova, Konstantin N. Vagin, Nikolai M. Vasilevski